Trending News

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

Supreme Court Eliminates Heightened Discrimination Standard Under Title VII

Cleaning the Cupboard—Six More Decisions in One Day, and a Largely Harmonious Court - SCOTUS Today

U.S. Supreme Court Holds Majority-Group Plaintiffs Are Not Subject to a Heightened Evidentiary Standard Under Title VII

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at the Advanced Therapeutics in Movement & Related Disorders® Congress
Posted On Tuesday, June 24, 2025
Corbus Pharmaceuticals to Participate in the 3rd Annual Piper Obesity Symposium
Posted On Tuesday, June 24, 2025
Syndax Announces FDA Priority Review of sNDA for Revuforj® (revumenib) in Relapsed or Refractory mNPM1 Acute Myeloid Leukemia
Posted On Tuesday, June 24, 2025
Abvance Therapeutics Secures Strategic Seed Financing & Leadership Expansion at ADA Scientific Sessions
Posted On Tuesday, June 24, 2025
Inventprise Announces Breakthrough in COVID-19 Conjugate Vaccine Study Published in Vaccine Journal
Posted On Tuesday, June 24, 2025
Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech
Posted On Tuesday, June 24, 2025
BioAdaptives Announces National Launch of Pawpa™ Regen
Posted On Tuesday, June 24, 2025
Olympia Pharmaceuticals Launches OlympiaYou.com: Empowering Patients Through Innovative Wellness and Sexual Health Support
Posted On Tuesday, June 24, 2025
Actuate Therapeutics Highlights Significant and Sustained Survival Benefit in Key Metastatic Pancreatic Cancer Patient Populations in Phase 2 Elraglusib Trial
Posted On Tuesday, June 24, 2025
Candel Therapeutics Announces $15 million Registered Direct Offering of Common Stock
Posted On Tuesday, June 24, 2025
Senti Bio to Present at the 2025 Synthetic Biology: Engineering, Evolution, & Design (SEED) Conference
Posted On Tuesday, June 24, 2025
CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer
Posted On Tuesday, June 24, 2025
THC Therapeutics, Inc. Announces Acquisition of Oregon and California Consortium of Cannabis Companies
Posted On Tuesday, June 24, 2025
Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation
Posted On Tuesday, June 24, 2025
Cellectar Biosciences Submits Phase 1b Clinical Trial Protocol to US Food and Drug Administration for CLR 125 to Treat Triple-Negative Breast Cancer (TNBC)
Posted On Tuesday, June 24, 2025
Journey Medical to Join Russell 2000® and Russell 3000® Indexes
Posted On Tuesday, June 24, 2025
Longeveron® Announces Completion of Enrollment of Pivotal Phase 2b Clinical Trial Evaluating Laromestrocel as a Treatment for Hypoplastic Left Heart Syndrome (HLHS)
Posted On Tuesday, June 24, 2025
Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025
Posted On Monday, June 23, 2025
Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders
Posted On Monday, June 23, 2025
Lyell Immunopharma to Participate in the H.C. Wainwright “HCW@Home” Series
Posted On Monday, June 23, 2025
Onco360 Has Been Selected as a National Specialty Pharmacy Partner for ROMVIMZA™ (vimseltinib)
Posted On Monday, June 23, 2025
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Monday, June 23, 2025
Terns Pharmaceuticals Presents Positive Data from Phase 1 Study of TERN-601 Once-daily Oral GLP-1R Agonist for Treatment of Obesity at 85th Annual American Diabetes Association Scientific Sessions
Posted On Monday, June 23, 2025
iMDx Reports Strong Head-to-Head Data in Kidney Transplant Rejection Testing
Posted On Monday, June 23, 2025
AIAA Welcomes ISS National Laboratory to 2025 ASCEND
Posted On Monday, June 23, 2025

Print